Vir Biotechnology, Inc. engages in the provision of technologies to treat and prevent infectious diseases. Its technology platforms include antibody, T cell, innate immunity, and siRNA. The company was founded by Robert Taylor Nelsen, Klaus Frueh, Jay Parrish, Lawrence Corey, and Louis Picker in 2016 and is headquartered in San Francisco, CA.
$29.43 +0.27 (0.93%)
As of 02/02/2023 09:46:30 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.